Global Herpes Zoster Drug Market, By Drug (Anti-Viral Agents, Anti-Inflammatory Agents, Analgesics, Anticonvulsants Agents, Corticosteroids, Tricyclic Antidepressants, Antihistamines and Others), Vaccine (Zostavax, Shingrix and Others), Route of Administration (Oral, Topical, Intravenous and Others), Distribution Channel (Online Pharmacy, Direct Tenders (Retailers and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Herpes Zoster Drug Market
The herpes zoster drug market is expected to witness market growth at a rate of 13.20% in the forecast period of 2021 to 2028. Data Bridge Market Research report on herpes zoster drug market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of cancer and HIV infection is escalating the growth of aviation analytics market.
Herpes Zoster, are also identified as shingles, is a viral disease triggered by the reactivation of varicella-zoster virus. It exhibits as a result of reactivation of the varicella virus laid inactive in the sensory ganglion following a chicken pox infection early in life or occasionally in utero.
Major factors that are expected to boost the growth of the herpes zoster drug market in the forecast period are the increase in the prevalence of herpes zoster and the rise in the elderly population. Furthermore, the technological developments and the developing of the healthcare infrastructure are propelling the growth of the herpes zoster drug market. On the other hand, the decline in the number of herpes zoster pipeline agents despite the rise in the prevalence incidence of the infection around the world is further estimated to impede the growth of the herpes zoster drug market in the timeline period.
In addition, the rise in the occurrences of cancer and HIV patients will further provide potential opportunities for the growth of the herpes zoster drug market in the coming years. However, the rise in the price of the antibodies might further create challenges for the growth of the herpes zoster drug market in the near future.
This herpes zoster drug market report provides details of new recent developments, trade regulations, import export analysis, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the herpes zoster drug market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Herpes Zoster Drug Market Scope and Market Size
The herpes zoster drug market is segmented on the basis of drug, vaccine, route of administration, distribution channel and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of drug, the herpes zoster drug market is segmented into anti-viral agents, anti-inflammatory agents, analgesics, anticonvulsants agents, corticosteroids, tricyclic antidepressants, antihistamines and others.
- On the basis of vaccine, the herpes zoster drug market is segmented into zostavax, shingrix and others.
- On the basis of route of administration, the herpes zoster drug market is segmented into oral, topical, intravenous and others.
- On the basis of distribution channel, the herpes zoster drug market is segmented into online pharmacy, direct tenders (retailers and others.
- On the basis of end users, the herpes zoster drug market is segmented into hospitals, homecare, specialty clinics and others.
Herpes Zoster Drug Market Country Level Analysis
The herpes zoster drug market is analysed and market size information is provided by country, drug, vaccine, route of administration, distribution channel and end users as referenced above.
The countries covered in the herpes zoster drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the herpes zoster drug market due to the increase in the elderly population. Furthermore, the rise in the number of cases suffering from herpes zoster (shingles) will further boost the growth of the herpes zoster drug market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the herpes zoster drug market due to the rise in the knowledge regarding the herpes zoster. Moreover, the increase in the vaccines and rising healthcare expenditure is further anticipated to propel the growth of the herpes zoster drug market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The herpes zoster drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Herpes Zoster Drug Market Share Analysis
The herpes zoster drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to herpes zoster drug market.
The major players covered in the herpes zoster drug market report are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Novartis AG, Bristol-Myers Squibb Company, Sanofi, Merck & Co., Inc., AstraZeneca, Abbott, Astellas Pharma Inc., NAL Pharma, TSRL, Inc, GeneOne Life Science, Beijing Minhai Biotechnology Co., Ltd, Foamix Pharmaceuticals Ltd, Maruho Co.,Ltd., Sinovac Biotech Ltd, Hepion Pharmaceuticals, CELGENE CORPORATION, among other domestic and global players. herpes zoster drug market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-